Utility of Point-of-Care Beta-hydroxybutyrate Testing for Predicting Diabetic Ketoacidosis in the Pediatric Emergency Department

Authors

Michelle Knoll, Children's Mercy HospitalFollow
Kelsee Halpin, Children's Mercy HospitalFollow
Ryan McDonough, Children's Mercy HospitalFollow

Publication Date

2019

Files

Mentor, Preceptor, Principle Investigator

Mentor: Kelsee Halpin MD, MPH

Abstract

The objective of our investigation was to describe the diagnostic characteristics of point-of-care capillary beta-hydroxybutyrate (BOHB) testing to predict diabetic ketoacidosis among pediatric patients presenting with hyperglycemia in the pediatric emergency department.

MeSH Keywords

Diabetic Ketoacidosis/diagnosis; Emergency Service, Hospital; Child; Adolescent; Diabetes Mellitus, Type 1; Sensitivity and Specificity

Keywords

DKA; BOHB; IDDM

Disciplines

Diagnosis | Emergency Medicine | Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism | Pediatrics

Notes

Presented at the Endocrine Society's ENDO 2019 conference in New Orleans, LA in March 2019.

Presented at the Children's Mercy Kansas City Research Days, May 2019.

Recommended Citation

Knoll, Michelle; Halpin, Kelsee; and McDonough, Ryan, "Utility of Point-of-Care Beta-hydroxybutyrate Testing for Predicting Diabetic Ketoacidosis in the Pediatric Emergency Department" (2019). Posters. 110.
https://scholarlyexchange.childrensmercy.org/posters/110